Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2574-42-7

Post Buying Request

2574-42-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2574-42-7 Usage

General Description

Bicyclo[2.2.2]octan-1-yl methanol, also known as the Endo-methanohydrophenanthrene, is a chemical compound with a bicyclic structure. It is a colorless liquid with a slightly sweet odor, and is commonly used in the fragrance and flavor industry. This chemical is mainly used as a fragrance ingredient in personal care products, perfumes, and household items. It can also be used as a flavoring agent in food and beverages. Bicyclo[2.2.2]octan-1-yl methanol is known for its ability to provide a fresh and clean scent, and is often used in combination with other fragrance ingredients to enhance the overall scent profile of a product. Additionally, it has been found to have potential applications in the pharmaceutical and medical fields.

Check Digit Verification of cas no

The CAS Registry Mumber 2574-42-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,7 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2574-42:
(6*2)+(5*5)+(4*7)+(3*4)+(2*4)+(1*2)=87
87 % 10 = 7
So 2574-42-7 is a valid CAS Registry Number.

2574-42-7Relevant articles and documents

MITOCHONDRIA-TARGETING PEPTIDES

-

, (2020/07/14)

Disclosed are analogs of SBT-20. The compounds are useful for the treatment and prevention of ischemia-reperfusion injury (e.g., cardiac ischemia-reperfusion injury) or myocardial infarction.

MITOCHONDRIA-TARGETING PEPTIDES

-

Page/Page column 62; 63, (2019/07/19)

Disclosed are non-natural peptides useful for the treatment and prevention of ischemia-reperfusion injury (e.g., cardiac ischemia-reperfusion injury) or myocardial infarction.

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

-

Page/Page column 157; 158, (2018/03/25)

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2574-42-7